Bernstein Initiates Outperform Rating on Vertex Pharmaceuticals with $49 PT

lunes, 12 de enero de 2026, 6:01 am ET1 min de lectura
MDLN--
VRTX--

Bernstein Initiates Outperform Rating on Vertex Pharmaceuticals with $49 PT

Bernstein Initiates Outperform Rating on Vertex Pharmaceuticals with $49 PT

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios